Convulsant bicuculline modifies CNS muscarinic receptor affinity

BMC Neuroscience

Volumn 7, Issue , 2006, Pages

  Schneider, Patricia G ^a   Rodríguez de Lorez Arnaiz, Georgina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BICUCULLINE; MUSCARINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EPILEPSY; GABAERGIC SYSTEM; HIPPOCAMPUS; LIGAND BINDING; MALE; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN FUNCTION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR SENSITIVITY; TONIC CLONIC SEIZURE;

ANIMALS; BICUCULLINE; BINDING, COMPETITIVE; BRAIN; CEREBELLUM; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; LIGANDS; MALE; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC;

EID: 33646745513     PISSN: 14712202     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-7-32     Document Type: Article

References (40)

1. Wasterlain CG, Farber DB, Fairchild MD: Synaptic mechanisms in the kindled epileptic focus: a speculative synthesis. In Advances in Neurology Edited by: Delgado-Escueta AV, Ward AA Jr, Woodbury DM, Porter RJ. New York: Raven Press; 1986:411-433.
2. Cox CL, Metherate R, Ashe JH: Modulation of cellular excitability in neocortex: muscarinic receptor and second messenger-mediated actions of acetylcholine. Synapse 1994, 16:123-136.
3. Peterson SL, Armstrong JJ: Muscarinic receptors mediate carbachol-induced inhibition of maximal electroshock seizures in the nucleus reticularis pontis oralis. Epilepsia 1999, 40:20-25.
4. Meldrum BS: The role of glutamate in epilepsy and other CNS disorders. Neurology 1994, 44:S14-S23.
5. Meldrum BS: Neurotransmission in epilepsy. Epilepsia 1995, 36:30-35.
6. Ribak CE: Epilepsy and the cortex. In Cerebral Cortex Edited by: Peters A. New York: Plenum Publishing Co; 1991:427-483.
7. Sprince H, Parker CM, Josephs J, Magazino J: Convulsant activity of homocysteine and other short-chain mercaptoacids: protection thereform. Ann N Y Acad Sci 1969, 166:323-325.
8. Rodríguez de Lores Arnaiz G, Alberici de Canal M, De Robertis E: Alteration of GABA system and Purkinje cells in rat cerebellum by the convulsant 3-mercaptopropionic acid. J Neurochem 1972, 19:1379-1385.
9. Rodríguez de Lores Arnaiz G, Alberici de Canal M, Robiolo B, Mistrorigo de Pacheco M: The effect of the convulsant 3-mercaptopropionic acid on enzymes of the γ-aminobutyrate system in the rat cerebral cortex. J Neurochem 1973, 21:615-623.
10. 3H]-quinuclidinyl benzilate binding to membranes of the striatum and cerebellum. Neurochem Int 1992, 20:591-597.
11. Schneider PG, Rodríguez de Lores Arnaiz G: Area-dependent CNS membranes response of muscarinic receptor to convulsant 3-mercaptopropionic acid. Mol Chem Neuropathol 1997, 32:1-9.
12. Schneider PG, Rodríguez de Lores Arnaiz G: Ligand binding to CNS muscarinic receptor is transiently modified by convulsant 3-mercaptopropionic acid administration. Neurochem Res 2000, 25:637-643.
13. Olsen RW, DeLorey TM: GABA and glycine. In Bask Neurochemistry Edited by: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD. New York: Lippincott-Raven; 1999:335-346.
14. Chang KJ, Jacobs S, Cuatrecasas P: Quantitative aspects of hormone receptor interactions. Effect of receptor concentration and measurement of dissociation constants of labeled and unlabeled hormones. Biochim Biophys Acta 1975, 406:294-303.
15. Houser CR: GABA neurons in seizure disorders; a review of immunocytochemical studies. Neurochem Res 1991, 16:295-300.
16. Ribak CE, Peterson GM, Roberts RC: Two abnormal GABAergic circuits in experimental models of epilepsy: morphoplogical correlates of human epilepsy. In Intractable Epilepsy Edited by: Schmidt D, Morselli PL. New York: Raven Press; 1986:61-73.
17. Roberts E: Failure of GABAergic inhibition: a key to local and global seizures. In Advances in Neurology Edited by: Delgado-Escueta AV, Ward AA Jr, Woodbury DM, Porter RJ. New York: Raven Press; 1986:319-341.
18. Dingledine R, McBain CJ: Glutamate and aspartate. In Basic Neurochemistry Edited by: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD. New York: Lippincott-Raven; 1999:315-333.
19. Pennell PB, Burdette DE, Ross DA, Henry TR, Albin RL, Sackellares JC, Frey KA: Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis. Epilepsia 1999, 40:38-46.
20. Hwa GGC, Avoli M, Oliver A, Villemure JG: Bicuculline-induced epileptogenesis in the human neocortex maintained in vitro. Exp Brain Res 1991, 83:329-339.
21. Masukawa LM, Higashima M, Hart GJ, Spencer DD, O'Connor MJ: NMDA receptor activation during epileptiform responses in the dentate gyrus of epileptic patients. Brain Res 1991, 562:176-180.
22. Zia-Gharib F, Webster RA: Effect of compounds modulating amino acid neurotransmission on the development and control of bicuculline-induced epileptogenic spiking in the rat. Neuropharmacology 1991, 30:995-1009.
23. Hamilton SE, Loose MD, Qi M, Levey AI, Hille B, McKnight GS, Idzerda RL, Nathanson NM: Disruption of the M1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci USA 1997, 94:13311-13316.
24. Bymaster FP, Carter PA, Yamada M, Gomeza J, Wess J, Hamilton SE, Nathanson NM, McKinzie DL, Felder CC: Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity. Eur J Neurosci 2003, 17:1403-1410.
25. Potier S, Psarropoulou C: Endogenous acetylcholine facilitates epileptogenesis in immature rat neocortex. Neurosci Lett 2001, 302:25-28.
26. Psarropoulou C, Dallaire F: Activation of muscarinic receptors during blockade of GABA(A)-mediated inhibition induces synchronous epileptiform activity in immature rat hippocampus. Neuroscience 1998, 82:1067-1077.
27. Khrestchatisky M, Ferhat L, Charton G, Bernard A, Polard H, Represa A, Ben-Ari Y: Molecular correlates between reactive and developmental plasticity in the rat hippocampus. J Neurobiol 1995, 26:426-436.
28. Millán MH, Chapman AG, Meldrum BS: Extracellular amino acid levels in hippocampus during pilocarpine-induced seizures. Epilepsy Res 1993, 14:139-148.
29. Sutula TP: Reactive changes in epilepsy: cell death and axon sprouting induced by kindling. Epilepsy Res 1991, 10:62-70.
30. 3H]-GABA release in the rat substantia nigra through muscarinic receptors localized on striatonigral terminals. Neuroscience 1994, 63:989-1002.
31. Marchi M, Sanguineti P, Raitieri M: Muscarinic receptors mediate direct inhibition of GABA release from rat striatal nerve terminals. Neurosci Lett 1990, 116:347-351.
32. Vella N, Ferraro G, Caravaglios A, Aloisio A, Sabatino M, La Grutta V: A feature of caudate control of focal hippocampal epilepsy: evidence for an anterograde pathway. Exp Brain Res 1991, 85:240-242.
33. Mendes Freitas R, Bezerra Felipe CF, Nascimento VS, Oliveira AA, Viana GSB, Fonteles MM de F: Pilocarpine-induced seizures in adult rats:monoamine content and muscarinic and dopaminergic receptor changes in the striatum. Comp Biochem Physiol Part C 2003, 136:103-108.
34. Pedigo NW Jr: Neurotransmitter receptor plasticity in aging. Life Sci 1994, 55:1985-1991.
35. Ondarza R, Trejo-Martínez D, Corona-Amezcua R, Briones M, Rocha L: Evaluation of opiod and muscarinic receptors in human epileptogenic neocortex: an autoradiography study. Epilepsia 2002, 43:230-234.
36. Yamamura HY, Snyder SH: Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 1974, 71:1725-1729.
37. Aguilar JS, Fonseca MI, Lunt GG: Differential effect of ethanol on muscarinic cholinergic binding to rat and locust neural membranes. Neurochem Res 1989, 14:763-770.
38. 3) muscarinic receptors. Mol Pharmacol 1991, 40:413-420.
39. 3H]-quinuclidinyl benzilate binding and protein synthesis in the striatum following chronic administrations of muscarinic agonist. Jpn J Pharmacol 1995, 67:83-86.
40. Lowry OH, Rosebrough N, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.